Revian Inc. has received from the United States Patent and Trademark Office (USPTO) U.S. Patent No. 10,265,258—the seminal patent on the use of proprietary color combinations of light to regenerate living tissue in the body.  

The claims in this issued patent cover the use of specific wavelengths of LED light to stimulate the body’s cellular generation of nitric oxide as well as to release the body’s natural nitric oxide reserves. Nitric oxide has a remarkably diverse range of biological functions as it is involved in the proper function of virtually every organ in the human body, and its decline is linked to many degenerative diseases of aging.  

“This is a groundbreaking approach to the therapeutic use of light,” says Dr. Nathan Stasko, co-inventor and Executive Chairman, Revian, Inc. (formerly PhotonMD Inc.). “We set out to decode the spectrum of light and identify which wavelengths encourage cells, tissues and organs to repair themselves.”

“By stimulating the body’s internal mechanisms for the generation and release of nitric oxide, we are able to realize the therapeutic benefits of nitric oxide in the body without the challenges of pharmaceutical drug development,” continues Dr. Stasko.

Revian Red is the first product to employ the therapeutic advances enabled by combining LED technology and nitricoxide medical research. This advanced medical device is clinically proven to stop hair loss and grow new hair, providing a potentially life-changing treatment for men and women suffering from androgenetic alopecia.

Revian’s parent company is KNOW Bio.

“Our patented dual-band technology can give new hope to the estimated 50 million men and 30 million women suffering from androgenetic hair loss in the United States and to hundreds of millions more around the globe,” says Brian Johnson, President Revian, Inc. “When you add a second wavelength and use LEDs to provide a whole new patient experience designed from the ground up to be comfortable, effective, safe and convenient—you have Revian Red, the most technologically advanced answer for these millions of sufferers.”